In this session, attendees will gain a better understanding of the EU MDR extension and how it impacts manufacturers. Other questions to be answered include:
• What are the pitfalls to avoid during the extension?
• Learn how notified bodies are dealing with the extensions – common challenges and advice.
• What is the impact of the extension for legacy v/s new products?
• What does this mean for Brexit? How will Switzerland act?
• What is the impact on US medical device reporting (QSR to QMS)
